SCHEMBL9358258

SCHEMBL9358258

CC(C)(C)OC(=O)NCCCCC(=O)N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.54
SIGMAR1 Q99720 2/20 0.52
CTSD P07339 1/20 0.51
CTSL P07711 1/20 0.51
CTSB P07858 1/20 0.51
CTSS P25774 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
USP2 O75604 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
RAB9A P51151 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 1/20 0.46
NR2F2 P24468 1/20 0.46
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9354347 0.96 SIGMAR1 (0.56) GLASIGMAR1CTSDCTSLCTSB
SCHEMBL1328433 0.90 CTSD (0.54) GLASIGMAR1CTSDCTSLCTSB
SCHEMBL4422293 0.87 SIGMAR1 (0.55) SIGMAR1TDP1RAB9AL3MBTL1NR2F2
SCHEMBL13799649 0.86 SIGMAR1 (0.65) SIGMAR1TDP1RAB9ANR2F2MAOA
SCHEMBL27004662 0.85 CTSL (0.50) GLASIGMAR1CTSDCTSLCTSB
SCHEMBL17742668 0.85 SIGMAR1 (0.58) SIGMAR1TDP1RAB9ANR2F2MAOA
SCHEMBL1929294 0.84 NR2F2 (0.60) SIGMAR1TDP1RAB9APOLBNR2F2
SCHEMBL1930614 0.84 NR2F2 (0.60) SIGMAR1TDP1RAB9APOLBNR2F2
SCHEMBL14542604 0.83 TDP1 (0.52) SIGMAR1TDP1RAB9ANR2F2MAOA
SCHEMBL11992513 0.82 SIGMAR1 (0.53) SIGMAR1TDP1RAB9ANR2F2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0300189-B1 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-11-02 EP disclosed
US-5223489-A Treatment of ypertension and heart failure UJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-29 US disclosed
US-5142048-A Enzyme inhibitor; carbamoyl group-containing acids FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-08-25 US disclosed
US-4921855-A New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-01 US disclosed
EP-0300189-A2 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-25 EP disclosed